7 ème. & 4 th Lebanese Gynecologic Oncologic Group Annual Meeting. Congrès d Oncologie Francophone & The Middle East Forum of Hematologic Malignancies
|
|
- Margaret Boyd
- 7 years ago
- Views:
Transcription
1 in collaboration with: 7 ème 7 Septième Congrès d Oncologie Francophone & The Middle East Forum of Hematologic Malignancies April 2016 Hilton Habtoor Hotel, Beirut - 13 & 4 th Lebanese Gynecologic Oncologic Group Annual Meeting In Collaboration with: 16 April 2016 Hilton Habtoor Hotel Beirut -
2
3 COMMITTEES Georges CHAHINE, MD President of the Congress Organizing and Scientific Chairs Georges CHAHINE, MD Muhieddine SEOUD, MD David ATALLAH, MD Hagop KANTARJIAN, MD Elias JABBOUR, MD Scientific Committee Rim ABDALLAH, MD Camille BOU SABA, MD Elias EL HAJAL, MD Janah EL HASSAN, MD Nadine EL KASSIS, MD Fadi GEARA, MD Michel GHOSSAIN, MD Karim NAUFAL, MD Georges WEHBE, MD Organizing Committee Elie ATTIEH, MD Ali BAZERBACHI, MD Nabil CHAMSEDDINE, MD Faycal EL KAK, MD Saadeldine EL ITANI, MD Ramzi FINAN, MD Wadih GHANAMÉ, MD Assad KESROUANI, MD Fersan MANSOUR, MD Marcel MASSOUD, MD Fady NASR, MD Joe SUIDAN, MD Lebanese Gynecology Oncology Group Middle East Forum of Hematologic Malignancies Georges CHAHINE, MD Muhieddine SEOUD, MD David ATALLAH, MD Honorary President Executive President Vice President Hagop KANTARJIAN, MD Co-Chair Georges CHAHINE, MD Co-Chair
4 COF-HEMATO Speakers YOUNG ONCOLOGIST Speakers Ali BAZERBACHI, MD Bertrand COIFFIER, MD Jean-Luc HAROUSSEAU, MD Ahmad IBRAHIM, MD Elias JABBOUR, MD Hagop KANTARJIAN, MD Guillermo Garcia MANERO, MD Suzan O BRIEN, MD LGOG Speakers U.S.A. U.S.A. U.S.A. U.S.A. Pamela ABDAYEM, MD Abir AHMADIE, MD Maya AL GHOR, MD Tarek ASSI, MD Ralph CHEBIB, MD Sabine EL HACHEM, MD Alain DAHER, MD Yolla DAKDOUKI, MD Tony IBRAHIM, MD Elie KASSOUF, MD Fouad KERBAJ, MD Nadine KHALIFE, MD Hampig KOURIE, MD Salem MANSOUR, MD Elie RASSI, MD Khalil SALEH, MD Riwa SAKR, MD Belgium Canada Belgium David ATTALLAH, MD Ali AYHAN, MD Turkey Lynette DENNY, MD South Africa Karim EL MASRI, MD U.A.E. Fadi GEARA, MD Michel GHOSSAIN, MD Ahmet GÖÇMEN, MD Turkey Tayfun GÜNGÖR, MD Turkey Kemal GÜNGÖRDÜK, MD Turkey Clement KHOURY, MD Mehmet Faruk KÖSE, MD Turkey Issam LATAYFE, MD Jordan Mehmet MUTLU MEYDANLI, MD Turkey Mehmet Murat NAKI, MD Turkey Nejat ÖZGÜL, MD Turkey Muzaffer SANCI, MD Turkey Ilker SELÇUK, MD Turkey Muhieddine SEOUD, MD H. Gökhan TULUNAY, MD Turkey Hiba UTHMAN, MD Mehmet Ali VARDAR, MD Turkey
5 4 th Lebanese Gynecologic Oncologic Group Annual Meeting Saturday April 16, :00 Registration 08:30-08:35 Welcoming Georges CHAHINE, MD Muhieddine SEOUD, MD Wadih GHANAMEH, MD 08:35-08:45 Introduction David ATALLAH, MD 08:45-10:00 Session I - Cervical Cancer: Prevention Moderators: Faisal EL-KAK, MD - Georges KEHDI, MD Sinan BERKMAN, MD - Assaad KESROUANI, MD 08:45-09:00 Loco-Regional Epidemiology: Incidence and Trends 09:00-09:15 PRIMARY PREVENTION: Prophylactic HPV Vaccines: Old and New Therapeutic Vaccines: Ready for Prime Time? 09:15-09:30 SECONDARY PREVENTION: New Screening Algorithms: 1ry HPV Testing - The Turkish Experience 09:30-09:45 ASCCP Guidelines for the Management of ASCUS and LSIL 09:45-10:00 ASCCP Guidelines for the Management of ASC-H, AGUS and HSIL 10:00-10:05 Disscussion Ali AYAHAN, MD Lynette DENNY, MD Nejat ÖZGÜL, MD Lynette DENNY, MD Mehmet Ali VARDAR, MD 10:05-10:20 Coffee Break 10:20-11:30 Session II - Early Cervical Cancer Moderators: Tony ZREIK, MD - Saadeddine ITANI, MD - Tayyup ŞİMŞEK, MD Karim NAWFAL, MD - Georges ABITAYEH, MD 10:20-10:35 Imaging in the Diagnosis, Pre-Op Evaluation, Michel GHOSSAIN, MD Staging and Follow-Up 10:35-10:50 Early Cervical Cancer: Fertility Sparing Procedures and Outcomes Karim EL MASRY, MD 10:50-11:00 Early Cervical Cancer: Role of Sentinel Lymph Node Sampling Muzaffer SANCI, MD Kemal GÜNGÖRDÜK, MD
6 4 th Lebanese Gynecologic Oncologic Group Annual Meeting Saturday April 16, :00-11:10 Early Cervical Cancer: Management of Low Volume Disease in HIC Positive, Sentinel Negative Lymph Node Patients 11:10-11:25 Early Cervical Cancer: Proper Surgical Staging: Can One Be Less Radical? 11:25-11:30 Disscussion Mehmet MUTLU MEYDANLI, MD Mehmet Faruk KÖSE, MD 11:30-11:45 Coffee Break 11:45-13:00 Session III - Early and Locally Advanced Cervical Cancer Moderators: Jihad EZZEDDINE, MD - Tuba ZENGIN, MD - Rana SKAFF, MD Elias HAJAL, MD - Hüsnü GÖKASLAN, MD 11:45-12:00 Early Cervical Cancer: Mehmet Murat NAKI, MD Role of Laparoscopic Surgery 12:00-12:15 Early Cervical Cancer: Ahmet GÖÇMEN, MD Role of Robotic Surgery 12:15-12:30 Advanced Cervical Cancer: Fadi GEARA, MD Concurrent Chemo-Radiotherapy 12:30-12:45 Locally Advanced Cervical Cancer: H. Gökhan TULUNAY, MD Surgical Management 12:45-13:00 Disscussion 13:00-13:15 Coffee Break 11:45-13:00 Session IV - Advanced Cervical Cancer Moderators: Şevki GÖKSUN GÖKULU, MD - Paul BARAKAT, MD - Anil CAKIR, MD Nawal TOUFAYLI, MD - Georges WEHBÉ, MD 13:15-13:30 Recurrent Cervical Cancer: Husnu CELIK, MD Role of LEER Procedure 13:30-13:45 Recurrent Cervical Cancer: Clement KHOURY, MD Role of Radiotherapy 13:45-14:00 Advanced and Metastatic Cervical Cancer: Role of Targeted Therapy Muhieddine SEOUD, MD
7 4 th Lebanese Gynecologic Oncologic Group Annual Meeting Saturday April 16, :00-14:45 Session V - Special Issues After Treatment Moderators: Janah EL HASSAN, MD - Tevfik GÜVENAL ÖZDEN, MD Altundağ ABDALLAH, MD - Adra Camille BOUSABA, MD 14:00-14:15 Is there a Role For Hysterectomy for Residual Disease after Chemo-Radiotherapy? 14:15-14:30 Short and Long Term Complications of The Treatment of Cervical Cancer 14:30-14:45 Advanced and Recurrent Cervical Cancer: Palliative Treatment Isam LATAIFEH, MD Tayfun GÜNGÖR, MD Ilker SELÇUK, MD Hiba UTHMAN, MD 14:45-15:00 Wrap Up Muhieddine SEOUD, MD David ATALLAH, MD 14:45 Lunch ADJOURN
8 7 ème Congrès d Oncologie Francophone & 7 Septième The Middle East Forum of Hematologic Malignancies Tuesday April 19, :00 Registration 09:00-09:10 Welcoming Address of the President of the Congress Address of the Co-Chairman of the Congress Georges CHAHINE, MD Hagop KANTARJIAN, MD 09:10-11:30 Young Oncologist Forum Moderators: Georges CHAHINE, MD - Fady NASR, MD - Rita RIZK, MD LUNG Updates in the Strategy of the Treatment of Lung Cancer Elie KASSOUF, MD BREAST CANCER Hormone Treatment, What Are the New Options Genetic and Breast Cancer Advances in HER2 Breast Cancer RENAL CELL CARCINOMA Updates in the Treatment of Renal Cell Carcinoma GASTRIC Updates in the Treatment of Gastric Cancer PROSTATE Chemotherapy in CRPC IMMUNOTHERAPY A New Option for Cancer Patients Updates On Check Point Inhibitors in Hematology Immunotherapy: The Dawn of the New Era: Promises & Challenges in Oncology Riwa SAKR, MD Fouad KERBAJ, MD Ralph CHEBIB, MD Khalil SALEH, MD Nadine KHALIFE, MD Alain DAHER, MD Yolla DAKDOUKI, MD Hampig KOURIE, MD Abir AHMADIE, MD 11:30-12:00 Coffee Break 12:00-12:30 Opening Ceremony 12:30-13:30 The Neo-Adjuvant Treatment of HER2 Positive Breast Cancer - Symposium Sponsored by Roche David ATALLAH, MD
9 7 ème Congrès d Oncologie Francophone & 7 Septième The Middle East Forum of Hematologic Malignancies Tuesday April 19, :30-14:30 Lunch Break 14:30-15:30 Young Oncologist Forum II Moderators: 15:30-15:45 Coffee Break Marwan MALAS, MD - Evelyne HELOU, MD - Marcel MASSOUD, MD Les Avancées Thérapeutiques Sabine EL HACHEM, MD Dans Le Mélanome Antiemetic Treatment for Cancer Patients Pamela ABDAYEM, MD in 2016 Growth Factor Use in Cancer Patients Maya AL GHOR, MD Metastase Celerebrale Cancer Du Colon Tony IBRAHIM, MD Characteristics of Incident Tarek ASSI, MD Testicular Cancer In : Single Institutional Experience Epidemiology and Survival Analysis of GIST in Elie RASSI, MD : Real Life Study from a Hospital Tumor Registry Hairy Cell Leukemia SALEM MANSOUR, MD 15:45-17:05 MDS & MPN Moderators: Ahmad IBRAHIM, MD - Oussama JRADI, MD 15:45-16:25 How I treat MDS Guillermo Garcia - MANERO, MD 16:25-17:05 How I treat MPN Ali BAZERBACHI, MD 17:05-18:00 Meet the Experts Session: Case Presentations Guillermo Garcia - MANERO, MD Elias JABBOUR, MD Bertrand COIFFIER, MD Suzan OBRIEN, MD Hagop KANTARIAN, MD
10 7 ème Congrès d Oncologie Francophone & 7 Septième The Middle East Forum of Hematologic Malignancies Wednesday April 20, :00 Registration 09:00-09:10 Welcoming Address of the President of the Congress Address of the Co-Chairman of the Congress Georges CHAHINE, MD Hagop KANTARJIAN, MD 09:00-10:30 Acute Leukemia Moderators: Nabil SHAMSEDDINE, MD - Georges CHAHINE, MD - David WEHBE, MD 09:00-09:45 How I Treat AML in 2016: Updates & Novel Therapy Hagop KANTARJIAN, MD 09:45-10:30 How I Treat ALL in 2016: Updates & Novel Therapy Elias JABBOUR, MD 10:30-11:00 Coffee Break 11:00-12:20 Chronic Leukemia Moderators: Ghazi NSOULI, MD - Abdel Fattah KHAIR, MD - Hadi GHANEM, MD 11:00-11:40 How I Treat CLL IN 2016: Updates & Novel Therapy Suzan O BRIEN, MD 11:40-12:20 How I Treat CML IN 2016: Updates & Novel Therapy Hagop KANTARJIAN, MD 12:20-13:20 Symposium - Sponsored by Gilead 13:20-14:30 Lunch Break 14:30-15:50 Lymphomas Moderators: Joseph MAKDESSI, MD - Adnan ATTALLAH, MD 14:30-15:10 Non-Hogkin Lymphoma in 2016: Bertrand COIFFIER, MD Updates & Novel Therapy 15:10-15:50 How I treat Hodgkin Disease in 2016 Georges CHAHINE, MD 15:50-16:10 Coffee Break 16:10-17:30 Multiple Myeloma Moderators: Khaled IBRAHIM, MD - Mouin MOUBARAK, MD 16:10-16:50 How I Treat Multiple Myeloma in 2016 : Jean Luc HAROUSSEAU, MD Updates and Targeted Therapy 16:50-17:30 How I Treat Multiple Myeloma in Relapses Ahmad IBRAHIM, MD
11
12 Roche and Roche Diagnostics
April 19-20, 2013 Hilton Habtoor Beirut - Lebanon. 2nd Announcement. 1 st LEBANESE GYNECOLOGIC ONCOLOGIC GROUP MEETING ( LSOG ) Scientific Program
April 19-20, 2013 Hilton Habtoor Beirut - Lebanon è 2nd Announcement 1 st LEBANESE GYNECOLOGIC ONCOLOGIC GROUP MEETING ( LSOG ) Scientific Program Scientific Committee - COF4/LSMO10 Prof. Georges Chahine
More informationCarcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Carcinoma of the Cervix Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Treatment Treatment Microinvasive (Stage IA1): Simple (extrafascial) hysterectomy/cone
More informationUpdates in Urology. The 7 th Congress of the Lebanese Urology Society. le 7 ème Congrès de la Société Libanaise d Urologie
The 7 th Congress of the Lebanese Urology Society Updates in Urology le 7 ème Congrès de la Société Libanaise d Urologie In Collaboration with Association Française d Urologie www.uro.org EAU Lecture 12-13
More informationMain Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.
Main Street Planning Group 180 East Main Street Suite 110 Patchogue, NY 11772 Tel: 631.647.4694 Fax: 631.647.4697 MainStreetPlanningGroup.com Presented by Ted Mageau Ted@MainStreetPlanningGroup.com Life
More informationWhat is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
More informationWhat is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationHow To Know If You Have Cancer At Mercy Regional Medical Center
MERCY REGIONAL CANCER CENTER 2012 CANCER PROGRAM ANNUAL REPORT Using 2011 Data Mercy Regional Cancer Center When you have cancer, you might think first of treatments chemotherapy and radiation. You want
More informationMultidiciplinary Management of Gastrointestinal Cancers. September 5-6, 2015, Radisson Blu Hotel Sisli- Istanbul AGENDA
Multidiciplinary Management of Gastrointestinal s September 5-6, 2015, Radisson Blu Hotel Sisli- Istanbul AGENDA Saturday, 5 September 2015 08:45 Welcome and Introduction Hakan Akbulut MD. Cem Börüban
More informationST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival
ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival It is logical that the Cancer Program Committee choose to review the Lung Site, as Lung is the second
More informationBristol Hospital Cancer Care Center 2015 Annual Report
Bristol Hospital Cancer Care Center 2015 Annual Report 2015 Annual Report Cancer Care Center At every point along the path, our team is there, keeping the focus on the most important team member - the
More information30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens
Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.
More informationFINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)
FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 1 st TURKISH-HELLENIC POSTGRADUATE CONTINUOUS MEDICAL EDUCATION MEETING MAY 6-9, 2011, IZMIR, TURKEY DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E.
More informationMonitoring Clinical Stage to Improve Care
Monitoring Clinical Stage to Improve Care Stephen Dreyer, MD, FACS Cancer Liaison State Chair Nebraska Fremont, NE M. Asa Carter, CTR Manager, Accreditation and Standards American College of Surgeons Chicago,
More informationMedical Oncology. Rotation Goals & Objectives for rotating residents. General Objectives THE UNIVERSITY OF BRITISH COLUMBIA
THE UNIVERSITY OF BRITISH COLUMBIA Department of Urologic Sciences Faculty of Medicine Gordon & Leslie Diamond Health Care Centre Level 6, 2775 Laurel Street Vancouver, BC, Canada V5Z 1M9 Tel: (604) 875-4301
More informationCancer treatment. TOP EUROPEAN CANCER EXPERTISE The path to recovery
Cancer treatment TOP EUROPEAN CANCER EXPERTISE The path to recovery 0% LAND OF HIGH QUALITY HEALTHCARE Located in Finland, a land of high quality healthcare, Helsinki University Hospital is regarded as
More informationLEBANON Med-Desire training sessions
LEBANON Med-Desire training sessions Financial instruments for distributed solar energy technologies Beirut, 17-18 November, 2015 COUNTRY VENUE OF THE TRAINING COURSE THE CROWNE PLAZA BEIRUT HOTEL HAMRA
More informationNEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
More informationEstimated New Cases of Leukemia, Lymphoma, Myeloma 2014
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
More informationFriday 29 th, October 2010
Friday 29 th, October 2010 15:00-17:00 Registration 17:00-18:00 Opening Ceremony 18:00-18:30 Refreshment Break 18:30-19:00 Plenary Lecture I Nazli Gad El Mawla Memorial Lecture Chairpersons: Prof. Dr.
More informationImmuno-Oncology Therapies to Treat Lung Cancer
Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own
More informationMedical Marijuana Use in Patients with History of SCCHN Treated with Radiotherapy
HEALTH SERVICES RESEARCH Assessment the Impact of Real-time Tumor Tracking & Reduced Planning Target Volume Margins on Quality-of-Life in Prostate Cancer Patients Treatment with Intensity Modulated Radiotherapy
More informationSite Specific Oncology Clinical Enrichment Brochure for non-ui Hospitals and Clinics staff
University of Iowa Hospitals and Clinics Services and Patient Care Nursing Clinical Education Center 4 West, General Hospital 319-356-4304 Tel Nursing CEU Credit: CEUs will be granted by UIHC (IBN Approved
More informationCADAVERIC DISSECTION COURSE MULTIDISCIPLINARY SURGICAL TECHNIQUES ON GYNECOLOGIC ONCOLOGY
CADAVERIC DISSECTION COURSE MULTIDISCIPLINARY SURGICAL TECHNIQUES ON GYNECOLOGIC ONCOLOGY TREATMENT OF ADVANCED OVARIAN CANCER WITH SPECIAL EMPHASIS ON CYTOREDUCTIVE SURGERY AND HIPEC October 18th-19th,
More informationPost-PET Restaging Cancer Form National Oncologic PET Registry
Post-PET Restaging Cancer Form National Oncologic PET Registry Facility ID #: Registry Case Number: Patient Name: Your patient had a PET scan on: mm/dd/yyyy. The PET scan was done for restaging of (cancer
More information2 2 nd" LOS 2014" Annual Meeting of The Lebanese Ophthalmological Society. CME credits 30-31 May, 2014
Under the High Patronage of the President of the Council of Ministers His Excellency Mr. Tammam Salam In collaboration with Department of Ophthalmology LOS 2014" 2 2 nd" Annual Meeting of The Lebanese
More informationFulfilling the Promise
Fulfilling the Promise Advancing the Fight Against Cancer: America s Medical Schools and Teaching Hospitals For more than a century, the nation s medical schools and teaching hospitals have worked to understand,
More information2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma
2 nd ESSO Advanced Course on the Surgical and Medical Management of Melanoma Focus on stage III and IV melanoma In partnership with the Society of Surgical Oncology (SSO) 12-14 November 2015 ATHENS (GR)
More informationCo-pay assistance organizations offering assistance
Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin
More informationCHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
More informationRadiation Therapy for Cancer Treatment
Radiation Therapy for Cancer Treatment Guest Expert: Kenneth, MD Associate Professor of Therapeutic Radiology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Dr. Ed and
More informationRole of clinical trials in professional development
Role of clinical trials in professional development Peeter Padrik Tartu University Hospital University of Tartu Estonian Society for Medical Oncology How we do treatment decisions? Personal experience?
More informationFor personal use only
The Company Announcements Platform ASX Limited By E-lodgement PTX Shareholder Newsletter 9 November 2015, Melbourne, Australia: Prescient Therapeutics Limited (ASX: PTX), a clinical stage oncology company,
More informationCancer Care Delivered Locally by Physicians You Know and Trust
West Florida Physician Office Building Johnson Ave. University Pkwy. Olive Road N. Davis Hwy. For more information on West Florida Cancer Center: 850-494-5404 2130 East Johnson Avenue Pensacola, Florida
More informationBig Data and Oncology Care Quality Improvement in the United States
Big Data and Oncology Care Quality Improvement in the United States Peter P. Yu, MD, FACP, FASCO President, American Society of Clinical Oncology Director of Cancer Research, Palo Alto Medical Foundation
More information2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Wednesday Oct 7th, 2015 Congress Center (Hörsaal 1 3) Marien Hospital Herne Accreditation by the Medical Chamber
More informationIn Practice Whole Body MR for Visualizing Metastatic Prostate Cancer
In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer Prostate cancer is the second most common cancer in men worldwide, accounting for 15% of all new cancer cases. 1 Great strides have
More informationBreast. Patient information. cancer clinical pathway
Breast Patient information cancer clinical pathway This leaflet was written to properly inform people following breast cancer treatment plan. It doesn t replace the dialogue with healthcare staff; it rather
More informationYour Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer
Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis
More informationGRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
More informationOncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
More information1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
More informationInvasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology
Invasive Cervical Cancer Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology Cervical Cancer Etiology Human Papilloma Virus (HPV): Detected in 99.7% of cervical cancers Cancer
More informationSECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic
More informationMOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
More informationNEOPLASMS C00 D49. Presented by Jan Halloran CCS
NEOPLASMS C00 D49 Presented by Jan Halloran CCS 1 INTRODUCTION A neoplasm is a new or abnormal growth. In the ICD-10-CM classification system, neoplastic disease is classified in categories C00 through
More informationPOLICY A. INDICATIONS
Alimta (pemetrexed) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 09/01/2007 Current Effective Date: 10/01/2015 POLICY A. INDICATIONS The indications below
More informationBreast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationLevel 1. Nutrition & Lifestyle Oncology Certificate
Level 1 Nutrition & Lifestyle Oncology Certificate ONE MODULE 1 A Cancer Diagnosis Learn what cancer is; how/why it develops; diagnostic tests; inflammatory/ hormonal connections; 5 most important steps
More informationSommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle
Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of
More informationNumber. Source: Vital Records, M CDPH
Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high
More informationOne out of every two men and one out of every three women will have some type of cancer at some point during their lifetime. 3
1. What is cancer? 2. What causes cancer?. What causes cancer? 3. Can cancer be prevented? The Facts One out of every two men and one out of every three women will have some type of cancer at some point
More information3 rd EURASIAN April 21-23, 2011 / Yalta - Crimea 3 rd EURASIAN April 21-23, 2011 / Yalta - Crimea EURASIN 3 rd April 21-23, 2011 / Yalta - Crimea SUMMARY Eurasia, describing European and Asian continents
More informationCarcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in
EVERYONE S GUIDE FOR CANCER THERAPY Malin Dollinger, MD, Ernest H. Rosenbaum, MD, Margaret Tempero, MD, and Sean Mulvihill, MD 4 th Edition, 2001 Vagina Jeffrey L. Stern, MD Carcinoma of the vagina is
More informationBest of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
More informationSMALL CELL LUNG CANCER
Protocol for Planning and Treatment The process to be followed in the management of: SMALL CELL LUNG CANCER Patient information given at each stage following agreed information pathway 1. DIAGNOSIS New
More informationGUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
More informationAchievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for
Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its
More informationHow To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
More informationOncology Program. MedStarGoodSam.org. 2012 Annual Report 2011 Statistical Data Breast Cancer Focus
MedStarGoodSam.org Oncology Program 2012 Annual Report 2011 Statistical Data Breast Cancer Focus 5601 Loch Raven Blvd. Baltimore, MD 21239 443-444-8000 PHONE 13-MGSH-0168.052013 Message from Our Chairman
More informationCancer: DNA Synthesis, Mitosis, and Meiosis
Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationFrequently Asked Questions About Ovarian Cancer
Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues
More informationLung Cancer: More than meets the eye
Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research
More informationProbe: Could you tell me about when?
PERIODIC ASSESSMENT OF TREATMENT AND VITAL/DISEASE STATUS Periodic Assessment of Cancer Treatment and Disease Status (To be administered to patient at 3 months and reviewed at 6, 9 and 12 months) Instructions:
More informationTABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...
CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and
More informationOvarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health
Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public
More informationAdvancing Therapies for Blood Cancers
Advancing Therapies for Blood Cancers Stuart L. Goldberg, MD Chief, Division of Leukemia John Theurer Cancer Center Hackensack University Medical Center Hackensack, NJ Associate Clinical Professor of Medicine
More informationUpdate in Hematology Oncology Targeted Therapies. Mark Holguin
Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning
More informationThe Ontario Cancer Registry moves to the 21 st Century
The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer
More informationMaster Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
More informationCancer of the Cervix
Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,
More informationHow To Raise Money For Rare Cancer Research
Our 2014 Impact Funding Allocations Cycle for Survival funds promise: Our donations launch and accelerate research studies and clinical trials that drive discovery. By helping fill the funding gap in rare
More informationALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
More informationASH Review. Wednesday, January 21, 2015. Renaissance Cleveland Hotel. 24 Public Square Cleveland, Ohio. 15th Annual
15th Annual ASH Review Wednesday, January 21, 2015 24 Public Square Cleveland, Ohio About the Course This course will provide hematologists, medical oncologists, radiation oncologists and nurses with current
More informationPancreatic Cancer: FDA Approved Treatments and Clinical Trials
Pancreatic Cancer: FDA Approved Treatments and Clinical Trials Vincent J Picozzi MD MMM Virginia Mason Medical Center Seattle WA 1 Pancreatic cancer is the hardest cancer of all to treat 2 Pancreatic cancer:
More information2014 Report of Cancer Program Activities for 2013
2014 Report of Cancer Program Activities for 2013 The University of Vermont Health Network-Central Vermont Medical Center (UVMHN-CVMC) Cancer Committee is pleased to present our Cancer Program Annual Report
More informationGoals and Objectives: Breast Cancer Service Department of Radiation Oncology
Goals and Objectives: Breast Cancer Service Department of Radiation Oncology The breast cancer service provides training in the diagnosis, management, treatment, and follow-up of breast malignancies, including
More informationCancer Clinical Trials: In-Depth Information
Cancer Clinical Trials: In-Depth Information The Drug Development and Approval Process 1. Early research and preclinical testing 2. IND application filed with FDA 3. Clinical trials (phases 1, 2, and 3)
More informationOverview: 1. Epidemiology of childhood cancer survivorship 2. Late effects 3. Palliative care of survivors 4. Examples
Childhood Cancer Survivorship Jacqueline Casillas, M.D., M.S.H.S. Associate Program Director of the UCLA-LIVESTRONG LIVESTRONGTM TM Center of Excellence for Survivorship Care Overview: 1. Epidemiology
More informationLeukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
More informationThe Cancer Patient Journey. Dr. Jaco Fourie
The Cancer Patient Journey Dr. Jaco Fourie The Cancer Patient Journey Prevention and health promotion Screening Diagnosis and staging Treatment Surveillance and survivorship End of life care The Cancer
More informationCredit Systems - Learning Approach and Currency - Practical Session UPA, October 11, 2012
Credit Systems - Learning Approach and Currency - Practical Session UPA, October 11, 2012 Group 1a: International Commercial Law Group members: Rana Mansour Tania Abdallah Rihab Sawaya Charbel Bou Maroun
More informationHosts. New Methods for Treating Colorectal Cancer
Hosts Anees Chagpar MD Associate Professor of Surgical Oncology Francine MD Professor of Medical Oncology New Methods for Treating Colorectal Cancer Guest Expert: Scott, MD Associate Professor in the Department
More informationWhat is neuroendocrine cervical cancer?
Key Points: 1. Neuroendocrine cancer of the uterine cervix is a rare and aggressive disease. 2. Treatment for neuroendocrine cervical cancer is usually more intensive than that for most other types of
More informationInvestigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008
Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. David.Risser@dshs.state.tx.us Epidemiologist Cancer Epidemiology and Surveillance Branch
More informationNew Brunswick Cancer Network. Cancer System Performance 2012
New Brunswick Cancer Network Cancer System Performance 2012 January 2014 TABLE OF CONTENTS BACKGROUND The New Brunswick Context... 1 New Brunswick Cancer Network... 2 INTRODUCTION... 4 LIST OF FIGURES...
More informationThe Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation
The Role of Clinical Practice Guidelines, Survivorship Care Plans, and Inter-sectoral Care in Cancer Rehabilitation Prof. Eva Grunfeld, MD, DPhil, FCFP Ontario Institute for Cancer Research/Cancer Care
More informationGuidelines for using V-CODES (Status Codes)
1 Disclaimer This presentation is intended only for use by Tulane University faculty, staff, and students. No copy or use of this presentation should occur without the permission of Tulane University.
More informationInnovations in Kidney Cancer
Innovations in Kidney Cancer Guest Expert: Harriet, MD Associate Professor of Medical Oncology Edward, MD Assistant Professor of Surgical Urology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer
More informationThere must be an appropriate administrative structure for each residency program.
Specific Standards of Accreditation for Residency Programs in Radiation Oncology 2015 VERSION 3.0 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation
More information4/15/2013. bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o. anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma
Chapter Sixteen Oncology bi/o carcin/ chem/o immun/o onc/o radi/o sarc/o Combining Forms Prefixes and Suffixes Carcinogenesis anabrachydysectoendoneo- -ectomy -genesis -oma -plasia -sarcoma Causes of cancer
More informationMeet Your Sparrow Cancer Center Team
Meet Your Sparrow Cancer Center Team Our integrated, multidisciplinary approach means every Patient is evaluated and cared for by a team managing all aspects of care from tests and treatments, to infusions,
More informationA23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
More informationTherapeutic and Prophylactic AdE1- LMPpoly-Based Adoptive T cell Immunotherapy for Epstein Barr Virus- Associated Nasopharyngeal Carcinoma
Therapeutic and Prophylactic AdE1 LMPpolyBased Adoptive T cell Immunotherapy for Epstein Barr Virus Associated Nasopharyngeal Carcinoma Corey Smith, AACR Meeting, New Orleans, 2016 I have the following
More informationGeneral Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationPediatric Oncology for Otolaryngologists
Pediatric Oncology for Otolaryngologists Frederick S. Huang, M.D. Division of Hematology/Oncology Department of Pediatrics The University of Texas Medical Branch Grand Rounds Presentation to Department
More informationKomorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
More information